MEXICO CITY, Oct. 24 /PRNewswire-FirstCall/ -- Genomma Lab Internacional,
S.A.B. de C.V. (BMV: LAB) ("Genomma" or "the Company"), a leading Mexican
over-the-counter ("OTC") pharmaceuticals and personal care products company
announced the following:
We are pleased to announce the appointment of Ms. Patricia Faci Villalobos
as the new Vice President of Operations of Genomma Lab Internacional S.A.B de
C.V., reporting to our Chief Executive Officer, Rodrigo Herrera. As Vice
President of Operations, Ms. Faci will lead the Sales, Supply Chain, IT,
Finance and Administration, R&D and International areas while our CEO will
continue to oversee Marketing, Commercial Strategy, and Corporate Relations
directly.
Ms. Faci was Chief Executive Officer of Grupo Quan for more than 4 years.
Previously with the same group she acted as Chief Executive Officer of
Laboratorios Kener and as Chief Financial Officer for "Helados Holanda."
Before Grupo Quan, Ms. Faci held various administrative and operative
positions at DESC: GIRSA (Grupo Industrial Resistol). Ms. Faci was President
of CANIFARMA (Camara Nacional de la Industria Farmaceutica) (2005-2007); Board
Member of CANIFARMA in 2004; Vice President of CANIFARMA in 2003 and has
participated in many industry-related chambers as well as associations. Ms.
Faci earned a graduate degree in Chemical Engineering from the Universidad La
Salle and participated in Top Management courses at the Instituto Panamericano
de Alta Direccion de Empresas.
We believe that with Ms. Faci's management expertise and leadership,
Genomma Lab will be in a better position to capitalize the existing
opportunities in the market.
Additionally, we are also pleased to announce the incorporation of Mr.
Oscar Villalobos-Torres as the Company's new Chief Financial Officer,
substituting Ms. Kristi King Etchberger.
Mr. Villalobos has worked in the past 10 years principally in Grupo IMSA
where he worked in various finance and administrative positions. He also
managed diverse M&A transactions and was involved in financial and strategic
planning activities. Before, Mr. Villalobos lead the treasury and planning
areas in Internacional de Ceramica from 1993 to 1998. Mr. Villalobos obtained
an MBA from the Universidad de Chihuahua; obtained a graduate degree in
Administration and Finance from University of Texas; has performed managerial
courses in the Instituto Panamericano de Alta Direccion de Empresa; has
studied International Business and Economic Law at George Washington
University; and has a graduate degree in Finance from Instituto Tecnologico y
de Estudios Superiores de Monterrey.
Company Description
Genomma Lab Internacional, S.A.B. de C.V. is one of the fastest growing
over-the-counter pharmaceutical and personal care products companies in
Mexico. Genomma develops, sells and markets a broad range of premium branded
products, many of which are leaders in the categories in which they compete in
terms of sales and market share. Through a combination of a successful new
products development process, consumer-oriented marketing, a broad retail
distribution network and a low-cost, highly flexible operating model, the
Company has grown its revenue at a compounded annual growth rate of 64.4% from
2005 to 2007.
The Company had net sales of Ps. 1,872.9 million and EBITDA of Ps. 460.5
million in 2007. Genomma's shares are listed on the Mexican Stock Exchange
under the ticker symbol "LAB.B" (Bloomberg: labb.mx).
Web Site: www.genommalab.com
SOURCE Genomma Lab Internacional
Investor Relations, Alejandro Diazayas, +52 55 5081 0000 Ext. 5106,
inversion@genommalab.com; or In New York, i-advize Corporate Communications,
Inc., +1-212-406-3691, genomma@i-advize.com
